Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
41,725,662
-
Share change
-
-267,928
-
Total reported value
-
$287,503,188
-
Put/Call ratio
-
650%
-
Price per share
-
$6.89
-
Number of holders
-
106
-
Value change
-
-$6,616,798
-
Number of buys
-
61
-
Number of sells
-
37
Institutional Holders of FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) as of Q2 2022
As of 30 Jun 2022,
FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,725,662 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., ARMISTICE CAPITAL, LLC, Deep Track Capital, LP, Cormorant Asset Management, LP, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Samsara BioCapital, LLC, EDBI Pte Ltd, and HHLR ADVISORS, LTD..
This page lists
106
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.